Chronic Kidney Disease Management in Diabetes

Diagnosis and Staging

• The American Diabetes Association and Kidney Disease: Improving Global Outcomes (KDIGO) guidelines define chronic kidney disease (CKD) as persistent abnormalities in kidney structure or function, with a glomerular filtration rate (GFR) <60 mL/min/1.73 m² or albuminuria ≥30 mg/24 hours for more than 3 months, which is relevant to patients with diabetes 5
• A 65-year-old patient with diabetes has CKD stage 3 based on serum creatinine levels and estimated GFR in the range of 30-59 mL/min/1.73 m², according to the National Kidney Foundation's guidelines 1, 3

Evidence Supporting Diabetic Etiology

• The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines state that CKD should be attributed to diabetes when macroalbuminuria is present or when microalbuminuria is present with diabetic retinopathy in type 1 diabetes of at least 10 years' duration, as seen in patients with long-standing diabetes 4
• The presence of significant proteinuria and diabetic retinopathy strongly supports diabetes as the underlying cause of kidney disease in patients with a 15-year history of diabetes, according to the American Journal of Kidney Diseases 2, 4

Management Considerations

• The American College of Cardiology recommends blood pressure control with ACE inhibitors or ARBs to reduce proteinuria in patients with CKD and diabetes 2, 5
• The American Diabetes Association recommends glycemic control to slow progression of microvascular complications in patients with diabetes and CKD 1, 7
• Statin therapy is recommended for cardiovascular risk reduction in patients with CKD and diabetes, according to the Kidney International guidelines 2

Referral to Nephrology

• The KDIGO guidelines recommend nephrology consultation when stage 4 CKD develops (GFR <30 mL/min/1.73 m²) to improve quality of care and delay dialysis in patients with diabetes and CKD 1, 5

Monitoring Recommendations

• The National Kidney Foundation recommends monitoring eGFR every 3 months in patients with moderately decreased GFR, such as those with CKD stage 3 1, 7
• Regular eye examinations are recommended to monitor retinopathy progression in patients with diabetes and CKD, according to the American Diabetes Association 1, 8